|
Volumn 2, Issue 3, 1997, Pages 229-234
|
MADIT provides the basis for developing therapeutic strategy for patients with severely depressed ventricular ejection fraction with nonsustained ventricular tachycardia
a a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
AUTOMATION;
CLINICAL TRIAL;
DEFIBRILLATOR;
DIAGNOSTIC VALUE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
IMPLANTATION;
META ANALYSIS;
MULTICENTER STUDY;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
SIGNAL AVERAGED ELECTROCARDIOGRAPHY;
SUDDEN DEATH;
|
EID: 0031415431
PISSN: 10742484
EISSN: None
Source Type: Journal
DOI: 10.1177/107424849700200310 Document Type: Review |
Times cited : (2)
|
References (25)
|